No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis

Boyang Zhou; Shuai Shang; Surong Liang; Lujing Xiang; Kefei Zhou; Suhua Wu; Linfeng Li

doi:10.5114/ada.2023.130543

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2023
vol. 40

Send email

Copy url:

abstract:

Letter to the Editor

No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis

Boyang Zhou

¹

,

Shuai Shang

¹

,

Surong Liang

¹

,

Lujing Xiang

¹

,

Kefei Zhou

¹

,

Suhua Wu

¹

,

Linfeng Li

¹

Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Adv Dermatol Allergol 2023; XL (4): 705-707

DOI: https://doi.org/10.5114/ada.2023.130543

Online publish date: 2023/11/09

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Zhou B, Shang S, Liang S, et al. No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(5):705-707. doi:10.5114/ada.2023.130543.

APA

Zhou, B., Shang, S., Liang, S., Xiang, L., Zhou, K.,  & Wu, S. et al. (2023). No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(5), 705-707. https://doi.org/10.5114/ada.2023.130543

Chicago

Zhou, Boyang, Shuai Shang, Surong Liang, Lujing Xiang, Kefei Zhou, Suhua Wu,  and Linfeng Li. 2023. "No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 40 (5): 705-707. doi:10.5114/ada.2023.130543.

Harvard

Zhou, B., Shang, S., Liang, S., Xiang, L., Zhou, K., Wu, S.,  and Li, L. (2023). No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(5), pp.705-707. https://doi.org/10.5114/ada.2023.130543

MLA

Zhou, Boyang et al. "No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 40, no. 5, 2023, pp. 705-707. doi:10.5114/ada.2023.130543.

Vancouver

Zhou B, Shang S, Liang S, Xiang L, Zhou K, Wu S et al. No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(5):705-707. doi:10.5114/ada.2023.130543.

No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis

Boyang Zhou 1 , Shuai Shang 1 , Surong Liang 1 , Lujing Xiang 1 , Kefei Zhou 1 , Suhua Wu 1 , Linfeng Li 1

Boyang Zhou

¹

,

Shuai Shang

¹

,

Surong Liang

¹

,

Lujing Xiang

¹

,

Kefei Zhou

¹

,

Suhua Wu

¹

,

Linfeng Li

¹